Auro Laboratories Limited scheduled the Board Meeting on August 23, 2025 to transact the business matter which are attached herewith.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Auro Laboratories held a meeting on August 23, 2025, and approved several key changes. Statutory Auditors M/s Kothari Jain & Associates (FRN 113041W) resigned effective August 23, 2025, citing pre-occupation with other commitments; they confirmed no concerns or disputes with management. To fill the casual vacancy, M/s B.L. Dasharda & Associates (FRN 112615W) has been appointed as Statutory Auditor from August 24, 2025, and also for a 5-year term from the 36th to 41st AGM, subject to shareholder approval. Mrs. Kavita Vijayakant Sharma has been re-appointed as Non-Executive Independent Director for a second 5-year term starting February 11, 2026. CS Padma Tapariya has been appointed as Company Secretary and Compliance Officer (KMP) effective October 1, 2025, and M/s GMJ & Associates has been appointed as Secretarial Auditors for 5 years starting April 1, 2025. The 36th AGM is scheduled for September 25, 2025, via video conferencing.
Routine board-level housekeeping changes — the auditor change is described as amicable with no concerns flagged, and the director/KMP appointments are normal governance actions. Shareholders should watch for the September 25 AGM to formally approve the new auditor and the director's re-appointment. No material negative signal for the stock.